Van Haren FM - Search Results

1

Preliminary report of a novel model using human umbilical vein endothelium in whole umbilical cord preparations to examine the in vitro effects of lipopolysaccharide and hypertonic saline on the gene expression of inflammatory mediators.

Van Haren FM, Sleigh J, Cursons J, Cursons RT, Jameson M. Van Haren FM, et al. Anaesth Intensive Care. 2015 Mar;43(2):277-9. Anaesth Intensive Care. 2015. PMID: 25735702 No abstract available.

2

Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study.

DeNucci G, Wilkinson T, Sverdloff C, Babadopulos T, Woodcock A, Shute J, Renato Guazelli P, Gerbase LF, Mourão PAS, Singh D, van Haren FMP, Page C. DeNucci G, et al. Among authors: van haren fmp. Pulm Pharmacol Ther. 2023 Jun;80:102212. doi: 10.1016/j.pupt.2023.102212. Epub 2023 Mar 27. Pulm Pharmacol Ther. 2023. PMID: 36990381 Free PMC article. Clinical Trial.

3

Gastrointestinal perfusion in septic shock.

van Haren FM, Sleigh JW, Pickkers P, Van der Hoeven JG. van Haren FM, et al. Among authors: van der hoeven jg. Anaesth Intensive Care. 2007 Oct;35(5):679-94. doi: 10.1177/0310057X0703500505. Anaesth Intensive Care. 2007. PMID: 17933153 Review.

4

The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients.

van Haren FM, Pickkers P, Foudraine N, Heemskerk S, Sleigh J, van der Hoeven JG. van Haren FM, et al. Among authors: van der hoeven jg. J Crit Care. 2010 Jun;25(2):358.e1-7. doi: 10.1016/j.jcrc.2010.02.008. Epub 2010 Apr 8. J Crit Care. 2010. PMID: 20381302

5

The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study.

van Haren FM, Sleigh J, Cursons R, La Pine M, Pickkers P, van der Hoeven JG. van Haren FM, et al. Among authors: van der hoeven jg. Ann Intensive Care. 2011 Nov 1;1(1):44. doi: 10.1186/2110-5820-1-44. Ann Intensive Care. 2011. PMID: 22044529 Free PMC article.

6

Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study.

van Haren FM, Sleigh J, Boerma EC, La Pine M, Bahr M, Pickkers P, van der Hoeven JG. van Haren FM, et al. Among authors: van der hoeven jg. Shock. 2012 Mar;37(3):268-75. doi: 10.1097/SHK.0b013e31823f152f. Shock. 2012. PMID: 22089205 Clinical Trial.

7

Transfusion practice and guidelines in Australian and New Zealand intensive care units.

Blood Observational Study Investigators of ANZICS-Clinical Trials Group; Westbrook A, Pettilä V, Nichol A, Bailey MJ, Syres G, Murray L, Bellomo R, Wood E, Phillips LE, Street A, French C, Orford N, Santamaria J, Cooper DJ. Blood Observational Study Investigators of ANZICS-Clinical Trials Group, et al. Intensive Care Med. 2010 Jul;36(7):1138-46. doi: 10.1007/s00134-010-1867-8. Epub 2010 May 4. Intensive Care Med. 2010. PMID: 20440603

8

Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial.

Young PJ, Bailey MJ, Bass F, Beasley RW, Freebairn RC, Hammond NE, van Haren FMP, Harward ML, Henderson SJ, Mackle DM, McArthur CJ, McGuinness SP, Myburgh JA, Saxena MK, Turner AM, Webb SAR, Bellomo R; REACTOR investigators; ANZICS Clinical Trials Group. Young PJ, et al. Intensive Care Med. 2019 Oct;45(10):1382-1391. doi: 10.1007/s00134-019-05729-4. Epub 2019 Oct 1. Intensive Care Med. 2019. PMID: 31576434 Clinical Trial.

9

The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.

Skrifvars MB, Luethi N, Bailey M, French C, Nichol A, Trapani T, McArthur C, Arabi YM, Bendel S, Cooper DJ, Bellomo R; EPO-TBI Investigators, the ANZICS Clinical Trials Group. Skrifvars MB, et al. Intensive Care Med. 2023 Jul;49(7):831-839. doi: 10.1007/s00134-023-07141-5. Epub 2023 Jul 5. Intensive Care Med. 2023. PMID: 37405413 Free PMC article.

10

Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator.

Akol H, Boon E, van Haren F, van der Hoeven J. Akol H, et al. Eur J Intern Med. 2002 Sep;13(6):389. doi: 10.1016/s0953-6205(02)00095-x. Eur J Intern Med. 2002. PMID: 12225785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters